Inspire Medical price target lowered to $220 from $230 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Inspire Medical (INSP) to $220 from $230 and keeps an Overweight rating on the shares. Though ...
Inspire: Q4 Earnings Snapshot
Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...
Inspire Medical price target lowered to $233 from $260 at Piper Sandler
Piper Sandler lowered the firm’s price target on Inspire Medical (INSP) to $233 from $260 and keeps an Overweight rating on the shares after ...